Chrom

Website

ChromaCode, Inc.

4 Investors
Biotechnology
CARLSBAD, CA

ChromaCode, Inc. is a biotechnology firm focused on revolutionizing diagnostic testing through its advanced PCR multiplexing technology solutions, enhancing efficiency and scalability in biomarker detection. By integrating cloud computing with traditional PCR methods, ChromaCode provides healthcare and research institutions with innovative approaches to diagnostic problem-solving.

Products & Team

HDPCRTM Technology

Diagnostic TechnologySeed

HDPCRTM Technology is ChromaCode's flagship product, a sophisticated diagnostic tool that markedly enhances traditional PCR testing. By integrating with the ChromaCode Cloud, it offers users an automated and streamlined testing experience.

Value Proposition

The technology addresses the critical need for efficient and scalable testing in diagnostics, enabling faster and more reliable biomarkers detection.

Pain Points

Existing limitations in PCR testing efficiency and scalability

Less than 24-hour turnaround timeMinimal hands-on requirementsAutomated result interpretation via cloud-based computingNo need for hardware or software installationHighly scalable testing capabilities

Paul Flook

Company Signatory
Chief Executive Officerat ChromaCode, Inc.
Joined ChromaCode, Inc.
February 2025
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
CARLSBAD, CA
Primary headquarters

Funding History

Total Raised:
$3.8M
E

Equity Offering

January 2025
$5.0M
Target
Progress
77%
Raised
$3.8M
Target
$5.0M
#000170467525000002